Print Departments and specialties Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens of specialties work together to ensure quality care and successful recovery. Departments that treat this condition Acute Leukemia/Myelodysplasia Group Bone Marrow Transplant Program Cancer Care at Mayo Clinic Hematology Oncology (Medical) Transplant Center Research Mayo Clinic doctors and scientists are researching ways to improve diagnosis and treatment of acute myelogenous leukemia. The Hematologic Malignancies Program conducts research related to acute myelogenous leukemia and other blood and bone marrow cancers. Cancer research is conducted in coordination with Mayo Clinic Comprehensive Cancer Center. Mayo Clinic Comprehensive Cancer Center receives funding from the U.S. National Cancer Institute and is designated as a comprehensive cancer center. This designation recognizes the institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment. PublicationsSee a list of publications about acute myelogenous leukemia by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine. Research Profiles Edit search filters close Narrow your search By location Arizona Florida Minnesota View all View all physicians • All Locations Hogan, William J. M.B., B.Ch. Minnesota Kaufmann, Scott H. M.D., Ph.D. Minnesota Khera, Nandita M.D., M.P.H. Arizona Litzow, Mark R. M.D. Minnesota Noel, Pierre M.D. Arizona Patnaik, Mrinal S. M.B.B.S. Minnesota Pruthi, Rajiv K. K. M.B.B.S. Minnesota Roy, Vivek M.D. Florida Tun, Han W. M.D. Florida By Mayo Clinic Staff Acute myelogenous leukemia care at Mayo Clinic Request an appointment Diagnosis & treatmentCare at Mayo Clinic Oct. 25, 2024 Print Living with acute myelogenous leukemia? Connect with others like you for support and answers to your questions in the Blood Cancers & Disorders support group on Mayo Clinic Connect, a patient community. Blood Cancers & Disorders Discussions Primary Myelofibrosis with JAK2: Anyone have Ojjaara (momelotinib)? 3 Replies Sun, Nov 03, 2024 chevron-right My Bone Marrow Transplant (BMT/SCT) story: Will you share yours? 532 Replies Sun, Nov 03, 2024 chevron-right What was your experience with bone marrow biopsy? 134 Replies Sun, Nov 03, 2024 chevron-right See more discussions Related Associated Procedures Bone marrow biopsy Bone marrow transplant Chemotherapy Lumbar puncture (spinal tap) Show more associated procedures News from Mayo Clinic Mayo Clinic Q&A podcast: Advancing treatments for acute myeloid leukemia Dec. 20, 2022, 02:08 p.m. CDT Products & Services Children’s Book: My Life Beyond Leukemia Skin Care Products for those in Cancer Treatment and Recovery Show more products and services from Mayo Clinic Mayo Clinic in Rochester, Minnesota, Mayo Clinic in Jacksonville, Florida, and Mayo Clinic in Phoenix/Scottsdale, Arizona, have been recognized among the top Cancer hospitals in the nation for 2024-2025 by U.S. News & World Report. Learn more about this top honor Acute myelogenous leukemiaSymptoms&causesDiagnosis&treatmentDoctors&departmentsCare atMayoClinic Research: It's all about patients Show transcript for video Research: It's all about patients [MUSIC PLAYING] Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is to advance how we can best help the patient, how to make sure the patient comes first in care. So in many ways, it's a cycle. It can start with as simple as an idea worked on in a laboratory, brought to the patient bedside, and if everything goes right — and let's say it's helpful or beneficial — then brought on as a standard approach. And I think that is one of the unique characteristics of Mayo's approach to research — that patient-centeredness — that really helps to put it in its own spotlight. CON-20369090 Patient Care & Health Information Diseases & Conditions Acute myelogenous leukemia